These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis. Jablonska PA; Muniz T; Ribeiro M; Liu ZA; Ye XY; Devaraja K; Laperriere N; Millar BA; Conrad T; Kongkham P; Butler M; Shultz DB J Neurooncol; 2023 Aug; 164(1):199-209. PubMed ID: 37552363 [TBL] [Abstract][Full Text] [Related]
26. Surgery of enlarging lesions after stereotactic radiosurgery for brain metastases in patients with non-small cell lung cancer with oncogenic driver mutations frequently reveals radiation necrosis: case series and review. Zhou F; Jiang L; Sun X; Wang Z; Feng J; Liu M; Ma Z APMIS; 2024 Jun; 132(6):375-381. PubMed ID: 38466886 [TBL] [Abstract][Full Text] [Related]
27. Adverse Radiation Effect and Disease Control in Patients Undergoing Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy for Brain Metastases. Koenig JL; Shi S; Sborov K; Gensheimer MF; Li G; Nagpal S; Chang SD; Gibbs IC; Soltys SG; Pollom EL World Neurosurg; 2019 Jun; 126():e1399-e1411. PubMed ID: 30902777 [TBL] [Abstract][Full Text] [Related]
29. Immune checkpoint inhibitor therapy may increase the incidence of treatment-related necrosis after stereotactic radiosurgery for brain metastases: a systematic review and meta-analysis. Kim PH; Suh CH; Kim HS; Kim KW; Kim DY; Aizer AA; Rahman R; Guenette JP; Huang RY Eur Radiol; 2021 Jun; 31(6):4114-4129. PubMed ID: 33241519 [TBL] [Abstract][Full Text] [Related]
30. Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC). Minniti G; Scaringi C; Lanzetta G; Anzellini D; Bianciardi F; Tolu B; Morace R; Romano A; Osti M; Gentile P; Paolini S Lung Cancer; 2019 Jun; 132():119-125. PubMed ID: 31097084 [TBL] [Abstract][Full Text] [Related]
31. Risk of symptomatic radiation necrosis in patients treated with stereotactic radiosurgery for brain metastases. Sayan M; Şahin B; Mustafayev TZ; Kefelioğlu EŞS; Vergalasova I; Gupta A; Balmuk A; Güngör G; Ohri N; Weiner J; Karaarslan E; Özyar E; Atalar B Neurocirugia (Astur : Engl Ed); 2020 Oct; ():. PubMed ID: 33082103 [TBL] [Abstract][Full Text] [Related]
33. First follow-up radiographic response is one of the predictors of local tumor progression and radiation necrosis after stereotactic radiosurgery for brain metastases. Sharma M; Jia X; Ahluwalia M; Barnett GH; Vogelbaum MA; Chao ST; Suh JH; Murphy ES; Yu JS; Angelov L; Mohammadi AM Cancer Med; 2017 Sep; 6(9):2076-2086. PubMed ID: 28776956 [TBL] [Abstract][Full Text] [Related]
34. Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease. Telera S; Fabi A; Pace A; Vidiri A; Anelli V; Carapella CM; Marucci L; Crispo F; Sperduti I; Pompili A J Neurooncol; 2013 Jun; 113(2):313-25. PubMed ID: 23525948 [TBL] [Abstract][Full Text] [Related]
35. The impact of sequencing PD-1/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasis. Kotecha R; Kim JM; Miller JA; Juloori A; Chao ST; Murphy ES; Peereboom DM; Mohammadi AM; Barnett GH; Vogelbaum MA; Angelov L; Suh JH; Ahluwalia MS Neuro Oncol; 2019 Aug; 21(8):1060-1068. PubMed ID: 30796838 [TBL] [Abstract][Full Text] [Related]
36. Dose-Volume Tolerance of the Brain and Predictors of Radiation Necrosis After 3-Fraction Radiosurgery for Brain Metastases: A Large Single-Institutional Analysis. Upadhyay R; Ayan AS; Jain S; Klamer BG; Perlow HK; Zoller W; Blakaj DM; Beyer S; Grecula J; Arnett A; Thomas E; Chakravarti A; Raval RR; Palmer JD Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):275-284. PubMed ID: 37574170 [TBL] [Abstract][Full Text] [Related]
37. Border Zone Maybe Correlated with Radiation Necrosis After Radiosurgery in Metastatic Brain Tumor. Lee C; Yoon SY; Hwang JH; Park SH; Kwon M; Yoon C; Lee K; Hahm MH; Park KS World Neurosurg; 2024 Jun; 186():e374-e381. PubMed ID: 38561029 [TBL] [Abstract][Full Text] [Related]
38. Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain Metastases. Uezono H; Nam D; Kluger HM; Sznol M; Hurwitz M; Yu JB; Chiang VL Am J Clin Oncol; 2021 Sep; 44(9):495-501. PubMed ID: 34432667 [TBL] [Abstract][Full Text] [Related]
39. Investigation of the risk factors in the development of radionecrosis in patients with brain metastases undergoing stereotactic radiotherapy. Doğan B; Demir H; Işık N; Gunalp G; Günbey HP; Yaprak G Br J Radiol; 2024 May; 97(1157):1022-1028. PubMed ID: 38426391 [TBL] [Abstract][Full Text] [Related]
40. Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS). Yan M; Lee M; Myrehaug S; Tseng CL; Detsky J; Chen H; Das S; Yeboah C; Lipsman N; Costa LD; Holden L; Heyn C; Maralani P; Ruschin M; Sahgal A; Soliman H J Neurooncol; 2023 Mar; 162(1):119-128. PubMed ID: 36914878 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]